|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$43.26 |
$43.92 |
$41.07 |
$42.37 |
676.10K | 04/22/2024 |
$43.23 |
$44.44 |
$42.40 |
$43.69 |
592.40K | 04/23/2024 |
$43.74 |
$45.58 |
$43.13 |
$45.11 |
836.70K | 04/24/2024 |
$45.52 |
$45.55 |
$43.61 |
$44.28 |
670.60K | 04/25/2024 |
$43.41 |
$43.99 |
$42.73 |
$43.85 |
470.80K |
|
Ultragenyx Pharmaceutical is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Co. has four commercially approved products, Crysvita® (burosumab) for the treatment of X-linked hypophosphatemia and tumor-induced osteomalacia, Mepsevii® (vestronidase alfa) for the treatment of mucopolysaccharidosis VII, or Sly Syndrome, Dojolvi® (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders, and Evkeeza® (evinacumab) for the treatment of homozygous familial hypercholesterolemia. | |
|
Ultragenyx Pharmaceutical (RARE) has the following price history information. Looking back at RARE historical stock prices for the last five trading days, on April 19, 2024, RARE opened at $43.26, traded as high as $43.92 and as low as $41.07, and closed at $42.37. Trading volume was a total of 676.10K shares. On April 22, 2024, RARE opened at $43.23, traded as high as $44.44 and as low as $42.40, and closed at $43.69. Trading volume was a total of 592.40K shares. On April 23, 2024, RARE opened at $43.74, traded as high as $45.58 and as low as $43.13, and closed at $45.11. Trading volume was a total of 836.70K shares. On April 24, 2024, RARE opened at $45.52, traded as high as $45.55 and as low as $43.61, and closed at $44.28. Trading volume was a total of 670.60K shares. On April 25, 2024, RARE opened at $43.41, traded as high as $43.99 and as low as $42.73, and closed at $43.85. Trading volume was a total of 470.80K shares.
RARE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ultragenyx Pharmaceutical shares, starting with a $10,000 purchase of RARE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$36.84 |
|
End price/share: |
$43.85 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
19.03% |
|
Average Annual Total Return: |
1.76% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$11,906.14 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/19/2024 | $42.37 | 04/22/2024 | $43.69 | 04/23/2024 | $45.11 | 04/24/2024 | $44.28 | 04/25/2024 | $43.85 |
|
|